250 related articles for article (PubMed ID: 32459453)
1. Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor.
Xavier R; de Carvalho RC; Fraietta R
Int Braz J Urol; 2021; 47(3):495-502. PubMed ID: 32459453
[TBL] [Abstract][Full Text] [Related]
2. Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013.
Stang A; Rusner C; Trabert B; Oosterhuis JW; McGlynn KA; Heidinger O
Andrology; 2019 Jul; 7(4):402-407. PubMed ID: 30578617
[TBL] [Abstract][Full Text] [Related]
3. Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors.
Panner Selvam MK; Alves MG; Dias TR; Pushparaj PN; Agarwal A
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650378
[TBL] [Abstract][Full Text] [Related]
4. Distribution of testicular tumors in Lebanon: a single institution overview.
Assi T; Rassy M; Nassereddine H; Sader-Ghorra C; Abadjian G; Ghosn M; Kattan J
Asian Pac J Cancer Prev; 2015; 16(8):3443-6. PubMed ID: 25921159
[TBL] [Abstract][Full Text] [Related]
5. Recent trends in the incidence of testicular germ cell tumors in the United States.
Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
[TBL] [Abstract][Full Text] [Related]
6. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
7. Effect of cryopreservation on semen quality in patients with testicular cancer.
Agarwal A; Tolentino MV; Sidhu RS; Ayzman I; Lee JC; Thomas AJ; Shekarriz M
Urology; 1995 Sep; 46(3):382-9. PubMed ID: 7660514
[TBL] [Abstract][Full Text] [Related]
8. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network.
Rives N; Perdrix A; Hennebicq S; Saïas-Magnan J; Melin MC; Berthaut I; Barthélémy C; Daudin M; Szerman E; Bresson JL; Brugnon F; Bujan L
J Androl; 2012; 33(6):1394-401. PubMed ID: 22837112
[TBL] [Abstract][Full Text] [Related]
9. Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients.
Suzuki K; Shin T; Shimomura Y; Iwahata T; Okada H
Hum Reprod; 2015 Dec; 30(12):2853-8. PubMed ID: 26428212
[TBL] [Abstract][Full Text] [Related]
10. Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients.
Furuhashi K; Ishikawa T; Hashimoto H; Yamada S; Ogata S; Mizusawa Y; Matsumoto Y; Okamoto E; Kokeguchi S; Shiotani M
Andrologia; 2013 Apr; 45(2):107-10. PubMed ID: 22690948
[TBL] [Abstract][Full Text] [Related]
11. Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumors.
Zhang C; Kawakami T; Okada Y; Okamoto K
Genes Chromosomes Cancer; 2005 May; 43(1):104-12. PubMed ID: 15672408
[TBL] [Abstract][Full Text] [Related]
12. GPs have key role in managing men with testicular cancer.
Josephides E; Gala A; Chowdhury S
Practitioner; 2014 Apr; 258(1770):19-23, 2-3. PubMed ID: 24881168
[TBL] [Abstract][Full Text] [Related]
13. K-RAS and N-RAS mutations in testicular germ cell tumors.
Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
[TBL] [Abstract][Full Text] [Related]
14. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
15. Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression.
Miyai K; Ito K; Nakanishi K; Tsuda H
Virchows Arch; 2019 Jun; 474(6):711-720. PubMed ID: 30877382
[TBL] [Abstract][Full Text] [Related]
16. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
Chieffi P; Chieffi S
J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
[TBL] [Abstract][Full Text] [Related]
17. Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014.
Brandt MP; Gust KM; Bon D; Tsaur I; Thomas C; Neisius A; Haferkamp A; Herrmann E; Bartsch G
Andrology; 2019 Jul; 7(4):408-414. PubMed ID: 31310057
[TBL] [Abstract][Full Text] [Related]
18. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
[TBL] [Abstract][Full Text] [Related]
20. CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors.
Fankhauser CD; Roth L; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Moch H; Bode PK; Beyer J; Hermanns T
BMC Cancer; 2019 Aug; 19(1):802. PubMed ID: 31412792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
